Low-dose aspirin confers a survival benefit in patients with pathological advanced-stage oral squamous cell carcinoma

Oral squamous cell carcinoma (OSCC) remains one of the most challenging clinical problems in the field due to its high rate of locoregional and distant metastases. However, studies that assess the association between aspirin use and survival in patients with OSCC are limited. Moreover, patients that...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Sheng-Dean, Wu, Shao-Chun, Chen, Wei-Chih, Wu, Ching-Nung, Chiu, Tai-Jan, Yang, Yao-Hsu, Li, Shau-Hsuan, Fang, Fu-Min, Huang, Tai-Lin, Hsiao, Chang-Chun, Chen, Chang-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387371/
https://www.ncbi.nlm.nih.gov/pubmed/34433896
http://dx.doi.org/10.1038/s41598-021-96614-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387371/
https://www.ncbi.nlm.nih.gov/pubmed/34433896
http://dx.doi.org/10.1038/s41598-021-96614-y

Ejemplares similares